Newtyn Management
$801M 13F equity value
39 Holdings
Quarter ended June 30, 2026
The latest 13F on file for Newtyn Management covers the quarter ended June 30, 2026. Institutional managers report holdings quarterly to the SEC, so each filing is a snapshot of positions held on that date.
Top Holdings
| Ticker | Company | Shares | Value | Weight |
|---|---|---|---|---|
| QDEL | QUIDELORTHO CORP | 6,625,000 | $116M | 14.5% |
| TBPH | THERAVANCE BIOPHARMA INC | 3,434,191 | $58M | 7.3% |
| INDV | INDIVIOR PHARMACEUTICALS INC | 1,305,795 | $54M | 6.7% |
| CNNE | CANNAE HLDGS INC | 3,169,631 | $46M | 5.7% |
| PAR | PAR TECHNOLOGY CORP | 2,418,754 | $42M | 5.3% |
| WEAV | WEAVE COMMUNICATIONS INC | 6,790,000 | $41M | 5.1% |
| TFX | TELEFLEX INCORPORATED | 305,000 | $39M | 4.8% |
| AIV | APARTMENT INVT & MGMT CO | 12,200,000 | $36M | 4.5% |
| MAGN | MAGNERA CORP | 2,800,000 | $33M | 4.1% |
| OCTV | OCTAVE INTELLIGENCE PLC | 1,922,160 | $31M | 3.9% |
Track Newtyn Management's 13F portfolio: $801M in reported holdings, 39 positions. Top holdings and quarterly changes on SentiSense.
This page is powered by the SentiSense API: GET /api/v1/institutional/institution/{slugOrCik}